CV Sciences (CVSI) Treasury Shares (2017 - 2018)

CV Sciences' (CVSI) quarterly Treasury Shares came in at $2.9 million in Q4 2018, up 47.5% quarter-over-quarter from $2.0 million in Q3 2017.

CV Sciences (CVSI) Treasury Shares (2017 - 2018) Analysis & Trends

CV Sciences has disclosed Treasury Shares across 2 years of filings, most recently posting $2.9 million for Q4 2018.

Treasury Shares for Q4 2018 came in at $2.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $2.9 million (changed N/A YoY), and the FY2018 annual result was $2.9 million, changed N/A from the prior year.
Treasury Shares came in at $2.9 million for Q4 2018 at CV Sciences, up from $2.0 million in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $2.9 million in Q4 2018 to a low of $1.0 million in Q1 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	107.00 Mn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	4.80 Mn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	1.42 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	17.13 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	19.58 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	7.24 Mn
10	CV Sciences	-	-	1.56 Mn	-

Download Data